In light of the COVID-19 pandemic, Psychiatry Advisor is making an effort to speak with providers from all professional backgrounds to gain insight into the field’s response to the current crisis.
Following clearance of an Investigational New Drug Application by the Food and Drug Administration, ViralClear announced that a phase 2 study evaluating merimepodib oral solution for the treatment of coronavirus disease 2019 (COVID-19) will be initiated.
A phase 2 study of Moderna’s vaccine candidate for COVID-19, mRNA-1273, is expected to start shortly following the Food and Drug Administration’s review of the Company’s Investigational New Drug (IND) application.
Mitigating the spread of a virus as infectious as SARS-CoV-2, the virus which causes COVID-19, requires having ample and accurate diagnostic tests available. However, in the United States community transmission began to occur before adequate testing measures could be implemented.
To shed light on how clinical practice is dealing in this time of COVID-19, we spoke with Jesse Clark, DO, Associate Program Director of Education at the Community East Family Medicine Residency and Clinical Chairperson of Family Medicine at Marian University College of Osteopathic Medicine, Indianapolis, Indiana.
Haymarket Medical Network, a part of business media company Haymarket Media, Inc., is proud to join the Ad Council’s first ever Private Marketplace (PMP) along with other partners Cadreon, The Trade Desk and Acxiom.
Hospitals have to remain current on how best to care for people with suspected or confirmed COVID-19 and educate these patients on appropriate discharge practices.
In a press briefing, NIAID Director and White House health advisor Dr Anthony Fauci compared the positive results of this highly powered, placebo-controlled trial to the discovery of the first HIV drug over 30 years ago. “This will be the standard of care,” said Fauci.
The use of telemedicine has been surging since the onset of coronavirus disease 2019 (COVID-19), with millions of Americans now using this medium for connecting with their clinicians.
